NACL incorporates a new subsidiary
NACL incorporates a new subsidiary

NACL incorporates a new subsidiary

Geyatee Deshpande Article rating: 4.0

NACL Industries announced that the company has incorporated a new wholly-owned subsidiary named as NACL Spec-Chem Limited.

Best performing debt funds
Best performing debt funds

Best performing debt funds

Shashikant Singh Article rating: 3.7

There is turmoil in the debt funds after Franklin Templeton India closed six of its debt mutual funds, however, most funds from debt category are generating positive returns in last month.

Sensex continues gaining streak for third consecutive session
Sensex continues gaining streak for third consecutive session

Sensex continues gaining streak for third consecutive session

Geyatee Deshpande Article rating: 5.0

Extending their gains for the third consecutive day in this week, Indian benchmark indices rose higher with Sensex, gaining by 1.89 per cent or 605.64 points to the level of 32,720.16 while, Nifty closed up by 1.84 per cent which is 172.45 points to reach the level of 9,553.35. Technically, Nifty was seen giving a major resistance breakout of 9,500 level as it made an intraday high at the level of 9,598.85 which eventually indicates the strengthening of the index.

Shemaroo Entertainment launches a flagship Hindi channel
Shemaroo Entertainment launches a flagship Hindi channel

Shemaroo Entertainment launches a flagship Hindi channel

Anthony Fernandes Article rating: 5.0

India's leading content powerhouse, Shemaroo Entertainment, announced that it is launching a new Hindi general entertainment channel (GEC)-Shemaroo TV, a free to air channel, targeting Hindi speaking markets of India.

IDFC First Bank to consider fundraising on May 1
IDFC First Bank to consider fundraising on May 1

IDFC First Bank to consider fundraising on May 1

Avalokita Pandey Article rating: 4.4

The stock of Indian banking company, IDFC First Bank, rose 1.12 per cent to Rs 22.50 in the early hours of Wednesday’s trading session after the bank informed that its board of directors will meet on May 1 to consider and approve fundraising by way of issue of equity shares of the bank on a preferential basis.

Lupin gets USFDA tentative approval for inhalation solutions
Lupin gets USFDA tentative approval for inhalation solutions

Lupin gets USFDA tentative approval for inhalation solutions

Apurva Joshi Article rating: 5.0

Lupin Limited has received a tentative approval for its Arformoterol Tartrate inhalation solution 15 mcg (base)/2 ml, unit-dose vials, from United States Food & Drug Administration (USFDA) to market generic version of Brovana inhalation solution, 15 mcg/2 ml of Sunovion Pharmaceuticals Inc.

What is sequencing risk all about?
What is sequencing risk all about?

What is sequencing risk all about?

Henil Shah Article rating: 4.3

There are various kinds of risk that we need to carry while investing. Sequencing risk is one such risk that specifically affects the retirement. So, what is sequencing risk? Let’s find out.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.0

The market opened in the green on April 29, 2020. The previous trading session witnessed the Sensex going up by 1.2 percent to end at 32,114 and the Nifty was up 1.1 percent to close at 9,380.

Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit
Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit

Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit

Anthony Fernandes Article rating: 4.1

Gujarat-based pharma company, Hester Biosciences Limited announced on Wednesday that it is joining hands with Indian Institute of Technology, Guwahati to work on the vaccine development against COVID-19. The agreement between the two parties was signed on April 15, 2020.

RSS
First21652166216721682170217221732174Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR